This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brown, M. S.
Right arrow Articles by Keith III, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown, M. S.
Right arrow Articles by Keith III, J. F.
Related Collections
Right arrow Blood

PEDIATRICS Vol. 104 No. 2 August 1999, pp. 210-215

Comparison Between Two and Five Doses a Week of Recombinant Human Erythropoietin for Anemia of Prematurity: A Randomized Trial

Received Aug 31, 1998; accepted Jan 8, 1999.

Mark S. Brown* and Julian F. Keith IIIDagger

From the * Department of Pediatrics, Presbyterian/St Luke's Medical Center, Denver, Colorado; and the Dagger  Department of Pediatrics, Naval Medical Center, San Diego, California.

Objective.  To compare the erythropoietic response between two and five times a week dosages of recombinant human erythropoietin (r-EPO) using the same weekly dose, 500 U/kg, in very low birth weight (VLBW) infants.

Study Design.  Eighty VLBW infants were stratified into two gestational age groups and randomized to receive 500 U/kg of r-EPO either two or five times a week; 72 infants completed at least 4 weeks of study. The primary outcome variable was absolute reticulocyte counts at 4 weeks. Secondary outcome variables were hematocrits, transfusions, iatrogenic blood losses, infections, and serum ferritins. Multiple regression analysis was used to evaluate the secondary outcome variables.

Results.  By 4 weeks, absolute reticulocyte counts were higher in the infants given r-EPO five times a week [mean (SEM)]: 173 000/mm3 (15 000) vs 220 000/mm3 (18 000), two versus five doses per week, respectively. Hematocrits, 34.9% (0.9) vs 34.1% (0.8), and transfusions per infant, 2.06 (0.4) vs 2.11 (0.4), were not different between the groups. Additionally, 79% of the variance in the amount of blood transfused was accounted for by iatrogenic blood loss, the latter primarily associated with number of days ventilated. Episodes of sepsis and necrotizing enterocolitis were significantly associated with decreased absolute reticulocyte counts and increased transfusions.

Conclusions.  More frequent dosing of the same weekly amount of r-EPO produced a significant and sustained increase in stimulated erythropoiesis in VLBW infants. The importance of this finding on reducing transfusions was not able to be demonstrated because this study was not intended to differentiate transfusions. In this population of infants and at the dose level of r-EPO, iatrogenic blood loss contributed more to transfusions than a lower level of erythropoiesis, the former primarily associated with mechanical ventilation. Based on this and other studies, when VLBW infants are at risk for greater phlebotomy losses, it may be justifiable to use more vigorous r-EPO treatment, and when at lower risk to use less frequent dosing to enhance cost-effectiveness.  Key words:  anemia, prematurity, transfusions, erythropoietin.




This article has been cited by other articles:


Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
A Pathak, P Roth, J Piscitelli, and L Johnson
Effects of vitamin E supplementation during erythropoietin treatment of the anaemia of prematurity
Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2003; 88(4): F324 - F328.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
M P Meyer, E Sharma, and M Carsons
Recombinant erythropoietin and blood transfusion in selected preterm infants
Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2003; 88(1): F41 - 45.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
L. R. Ment, H. S. Bada, P. Barnes, P. E. Grant, D. Hirtz, L. A. Papile, J. Pinto-Martin, M. Rivkin, and T. L. Slovis
Practice parameter: Neuroimaging of the neonate: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
Neurology, June 25, 2002; 58(12): 1726 - 1738.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
R. K. Ohls, R. A. Ehrenkranz, L. L. Wright, J. A. Lemons, S. B. Korones, B. J. Stoll, A. R. Stark, S. Shankaran, E. F. Donovan, N. C. Close, et al.
Effects of Early Erythropoietin Therapy on the Transfusion Requirements of Preterm Infants Below 1250 Grams Birth Weight: A Multicenter, Randomized, Controlled Trial
Pediatrics, October 1, 2001; 108(4): 934 - 942.
[Abstract] [Full Text] [PDF]